Back to Report Store Home

Biobanking: Key Operational, Regulatory and Ethical Trends Within the R&D and Commercial Landscape

  • Published: Oct-2018
  • Report Code: GBI091CBR
  • Report Format: pdf

Description

List of Figures

Figure 1: Biobanking, Typical Biobanking Workflow, 2018 7

Figure 2: Biobanking, Classification of Biobanks, 2018 13

Figure 3: Biobanking, Services Provided by Public Biobanks, 2018 18

Figure 4: Biobanking, Services Provided by Commercial Biobanks, 2018 18

Figure 5: Biobanking, Contribution of Biobanks in Drug Discovery and Development, 2018 37

Figure 6: Biobanking, NIH Funding for Regenerative Medicine ($m), 2008 – 2018 38

Figure 7: Biobanking, Global Venture Capital Investment in Regenerative Medicine, 2010–2016 38

Figure 8: Biobanking, Overview of the Cost Elements of Biobanks, 2018 39

Figure 9: Biobanking, Global Clinical Trial Activity Using Adipose Tissue-Derived Stem Cells, 2008–2017 42

Figure 10: Biobanking, Global, Completed Clinical Trials Using Adipose Tissue-Derived Stem Cells by Therapy Type, Therapy Area, Sponsor and Region, 2008– 2018 43

Figure 11: Biobanking, Global, Ongoing and Planned Clinical Trials Using Adipose Tissue-Derived Stem Cells by Therapy Type, Therapy Area, Sponsor and Region, 2012–2022 45

Figure 12: Biobanking, Global, Clinical Trial Activity Using Bone Marrow-Derived Stem Cells, 2008–2017 46

Figure 13: Biobanking, Global, Completed Clinical Trials Using Bone-Marrow Derived Stem Cells by Type, 2008–2018 47

Figure 14: Biobanking, Global, Completed Clinical Trials Using Bone-Marrow Derived Stem Cells by Therapy Area, Sponsor and Region, 2008 – 2018 48

Figure 15: Biobanking, Global, Ongoing and Planned Clinical Trials Using Bone-Marrow Derived Stem Cells by Type, 2008–2035 49

Figure 16: Biobanking, Global, Ongoing and Planned Clinical Trials Using Bone-Marrow Derived Stem Cells by Therapy Area, Sponsor and Region, 2008–2035 50

Figure 17: Biobanking, Global, Clinical Trial Activity Using Umbilical Cord Blood-Derived Stem Cells, 2008–2017 51

Figure 18: Biobanking, Global, Completed Clinical Trials Using Umbilical Cord Blood-Derived Stem Cells by Type, 2008–2018 52

Figure 19: Biobanking, Global, Completed Clinical Trials Using Umbilical Cord Blood-Derived Stem Cells by Therapy Area, Sponsor Type and Region, 2008–2018 53

Figure 20: Biobanking, Global, Ongoing and Planned Clinical Trials Using Umbilical Cord Blood-Derived Stem Cells by Type, 2008–2025 54

Figure 21: Biobanking, Global, Ongoing and Planned Clinical Trials Using Umbilical Cord Blood-Derived Stem Cells by Therapy Area, Sponsor and Region, 2008–2025 55

Figure 22: Biobanking, Front-End Business of 23andMe, 2018 59

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$2995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$5990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$8985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards